N-(5-BROMOIMIDAZO[1,2-A]PYRIDIN-2-YL)-2,2,2-TRIFLUOROACETAMIDE, 95.0%, 250mg

[1-(Pyridin-2-yl)piperidin-4-yl]methanamine, 95.0%, 100mg

2-Fluoronicotinamide, 97.0%, 5g

4-Aminocyclohexan-1-ol, 95.0%, 1g

Índice de refracción BRIX estándar, 11,5% stab. Sacarosa, 1.35015 (20 °C), 15 ml

Ne-Boc-L-lysine amide hydrochloride, 95.0%, 5g

TERT-BUTYL 4-(4-FORMYL-3-HYDROXYPHENYL)PIPERAZINE-1-CARBOXYLATE, 95.0%, 5g

4-Methyl-1-phenyl-3-pyrazolidone>98.0%(HPLC)(T)25g

4-Bromo-5-fluoro-2-methoxybenzaldehyde, 98%, 5g

3-(3-(Diisopropylamino)-1-phenylpropyl)-4-hydroxybenzaldehyde, 98%, 250mg

1,2,5,6-TETRAHYDROPYRIDINE-3-CARBOXYLIC ACID HCL, 95%, 100mg

4-Methoxypyridine-2,6-dicarboxylic acid, 95.0%, 5g

1H-Pyrrolo[2,3-b]pyridine-2,3-dione, 95.0%, 1g